RE:RE:RE:RE:I am still holding onto my shares.My post makes sense. Your response is juvenile and silly. The company is followed by very few which is why the volume is so small. However, that does not mean there are no shareholders in the stock, fella.
Again, revenues declined quarter to quarter which is not good. If you listened to the last earnings call, analysts went after Ken on that and i am not sure his response was completely reassuring. He has indicated business was doing great prior so to see weak numbers was a surprise. Of couse Ken said approval was very likely and we see how that turned out. The stock did hold up after weak earnings because Ken indicated, as i said, approval was very likely so investors held on because this drug was going to be the huge revenue driver going forward. Now we have no idea what will happen. Will this be resolved in a few months, year, years? Who knows? And even if they get approval, does the stock shoot higher or will it be a wait and see approach to how the drug sells. You better hope that Ken delivers better numbers than last quarter because if they continue to decline, you will see continued weakness.
Sorry fella, this is the truth no matter how much you try to deny it